This topic contains a solution. Click here to go to the answer

Author Question: L-DOPA is given to a patient with Parkinson's Disease because a. dopamine cannot cross the ... (Read 38 times)

vicotolentino

  • Hero Member
  • *****
  • Posts: 552
L-DOPA is given to a patient with Parkinson's Disease because
 
  a. dopamine cannot cross the blood-brain barrier.
  b. serotonin cannot cross the blood-brain barrier.
  c. L-DOPA is converted to norepinephrine.
  d. L-DOPA is converted to epinephrine.
  e. dopamine is too effective when it crosses the blood-brain barrier, resulting in schizophrenia-like symptoms.

Question 2

Which of the following is classified as an indolamine?
 
  a. glycine
  b. serotonin
  c. dopamine
  d. acetylcholine
  e. norepinephrine



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

peilian

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

Answer: a. dopamine cannot cross the blood-brain barrier.

Answer to Question 2

Answer: b. serotonin




vicotolentino

  • Member
  • Posts: 552
Reply 2 on: Jun 22, 2018
:D TYSM


parker125

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

For a complete list of videos, visit our video library